Treatment Effectiveness and Tolerability of Long-term Adjuvant First- and Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor at Different Doses in Patients With Stage IIA–IIIB Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Retrospective Study
Journal
Frontiers in Surgery
Journal Volume
9
Date Issued
2022
Author(s)
Publisher
Frontiers Media S.A.
Type
journal article